Bigot et al. identified splicing factor gene SF3B1 (splicing factor 3B subunit 1) mutation as a mechanism for tumour neoantigen production that is aberrantly expressed in tumours specific to each individual patient [87]. Here, SF3B1 is linked to neoplasm.